Thanks for posting that! Tombrady threw that crap out on the other board. I could not find any comment from her about Kevetrin in the limited time I had today. It makes sense now though, what a laughable conclusion to draw! A British cancer researcher does not know the details about an American P53 drug that hasn't completed a Phase 1 trial yet so she has dismissed Kevetrin! Smacks of Desperation!
